SG11201604972TA - Fgf-18 formulation in alginate/collagen hydrogels - Google Patents

Fgf-18 formulation in alginate/collagen hydrogels

Info

Publication number
SG11201604972TA
SG11201604972TA SG11201604972TA SG11201604972TA SG11201604972TA SG 11201604972T A SG11201604972T A SG 11201604972TA SG 11201604972T A SG11201604972T A SG 11201604972TA SG 11201604972T A SG11201604972T A SG 11201604972TA SG 11201604972T A SG11201604972T A SG 11201604972TA
Authority
SG
Singapore
Prior art keywords
fgf
alginate
formulation
collagen hydrogels
hydrogels
Prior art date
Application number
SG11201604972TA
Inventor
Fabiana Canal
Presti Caterina Lo
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of SG11201604972TA publication Critical patent/SG11201604972TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/26Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/505Stabilizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • A61L2300/414Growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/06Flowable or injectable implant compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/06Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Polymers & Plastics (AREA)
SG11201604972TA 2013-12-24 2014-12-23 Fgf-18 formulation in alginate/collagen hydrogels SG11201604972TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13199591 2013-12-24
PCT/EP2014/079205 WO2015097236A2 (en) 2013-12-24 2014-12-23 Fgf-18 formulation in alginate/collagen hydrogels

Publications (1)

Publication Number Publication Date
SG11201604972TA true SG11201604972TA (en) 2016-07-28

Family

ID=49882942

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201604972TA SG11201604972TA (en) 2013-12-24 2014-12-23 Fgf-18 formulation in alginate/collagen hydrogels

Country Status (17)

Country Link
US (1) US9795714B2 (en)
EP (1) EP3086822B1 (en)
JP (1) JP6487448B2 (en)
KR (1) KR102434024B1 (en)
CN (1) CN106068131B (en)
AU (1) AU2014372578B2 (en)
BR (1) BR112016014717B1 (en)
CA (1) CA2934638C (en)
ES (1) ES2806026T3 (en)
HK (1) HK1225657A1 (en)
IL (1) IL246407B (en)
MX (1) MX368970B (en)
NZ (1) NZ721597A (en)
RU (1) RU2698210C2 (en)
SG (1) SG11201604972TA (en)
WO (1) WO2015097236A2 (en)
ZA (1) ZA201604610B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2658909C2 (en) 2013-02-14 2018-06-26 НАНОПАРЕЙЛ, ЭлЭлСи Electrospun hybrid nanofibre felt
BR112016014578B1 (en) 2013-12-24 2023-01-24 Ares Trading S.A LIQUID FORMULATION SUITABLE FOR INTRA-ARTICULAR INJECTION, METHOD FOR PRODUCING A HYDROGEL COMPRISING FGF-18, HYDROGEL AND MANUFACTURED ARTICLE
AU2015220785B2 (en) * 2014-02-20 2018-07-19 Merck Patent Gmbh Implant comprising FGF-18
US10408686B2 (en) * 2016-01-15 2019-09-10 Temptime Corporation Gel-based temperature indicators
EP3821920A4 (en) * 2018-07-13 2022-03-02 T-ACE Medical Co., Ltd. Combination for endoscopic surgery
US20210340481A1 (en) * 2018-08-10 2021-11-04 Mochida Pharmaceutical Co., Ltd. Alginate hollow microfiber
EP3878476A4 (en) * 2018-11-06 2022-07-27 National Cancer Center Alginic acid-based injectable hydrogel system
CN111068116B (en) * 2019-12-28 2022-03-22 河北柯瑞生物医药有限公司 Cartilage repair temperature-sensitive gel for injection and preparation method thereof
WO2021228402A1 (en) * 2020-05-14 2021-11-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Composite product for the osteoarticular regeneration of cartilage lesion
CN112263505A (en) * 2020-10-29 2021-01-26 广州栋方生物科技股份有限公司 Copper peptide composition and preparation method and application thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2254350A1 (en) * 1998-11-17 2000-05-17 Hsc Research And Development Limited Partnership Method for bioengineering cartilage
US6451346B1 (en) * 1998-12-23 2002-09-17 Amgen Inc Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
US6355204B1 (en) * 2000-06-07 2002-03-12 Owens-Brockway Plastic Products Inc. Method of manufacturing a dual-chamber container
PT1517698E (en) * 2002-06-21 2014-11-19 Novo Nordisk Healthcare Ag Stabilised solid compositions of factor viia polypeptides
US20040136970A1 (en) * 2002-10-07 2004-07-15 Ellsworth Jeff L. Methods for administering FGF18
JP5367266B2 (en) 2004-10-12 2013-12-11 エフエムシー バイオポリマー エイエス Self-gelling alginate system and use thereof
US8741326B2 (en) * 2006-11-17 2014-06-03 Abbott Cardiovascular Systems Inc. Modified two-component gelation systems, methods of use and methods of manufacture
BRPI0906553A2 (en) * 2008-04-14 2015-07-07 Adocia '' Open implant consisting of osteogenic composition and method of implant preparation ''
JP2011160817A (en) * 2010-02-04 2011-08-25 Univ Of Tokyo Implantation support material
SG189402A1 (en) * 2010-10-15 2013-05-31 Univ Kyoto Sustained-release pharmaceutical composition
EP2678048B1 (en) * 2011-02-22 2018-11-21 Institut National de la Sante et de la Recherche Medicale (INSERM) Nano-reservoirs technology for use in bone and/or cartilage regeneration
TWI527590B (en) 2011-06-17 2016-04-01 艾瑞斯貿易公司 Freeze-dried formulations of fgf-18
BR112016014578B1 (en) 2013-12-24 2023-01-24 Ares Trading S.A LIQUID FORMULATION SUITABLE FOR INTRA-ARTICULAR INJECTION, METHOD FOR PRODUCING A HYDROGEL COMPRISING FGF-18, HYDROGEL AND MANUFACTURED ARTICLE

Also Published As

Publication number Publication date
BR112016014717A2 (en) 2017-09-19
AU2014372578A1 (en) 2016-07-14
JP6487448B2 (en) 2019-03-20
RU2016129817A3 (en) 2018-08-24
EP3086822B1 (en) 2020-04-15
ZA201604610B (en) 2018-11-28
CA2934638A1 (en) 2015-07-02
IL246407B (en) 2020-01-30
ES2806026T3 (en) 2021-02-16
RU2016129817A (en) 2018-01-30
MX368970B (en) 2019-10-23
KR20160101163A (en) 2016-08-24
MX2016008442A (en) 2017-01-11
AU2014372578A2 (en) 2016-11-17
HK1225657A1 (en) 2017-09-15
KR102434024B1 (en) 2022-08-22
US20160303291A1 (en) 2016-10-20
US9795714B2 (en) 2017-10-24
WO2015097236A3 (en) 2015-09-17
RU2698210C2 (en) 2019-08-23
BR112016014717B1 (en) 2020-12-01
JP2017502042A (en) 2017-01-19
AU2014372578B2 (en) 2018-03-01
CN106068131B (en) 2020-01-17
CA2934638C (en) 2022-07-12
EP3086822A2 (en) 2016-11-02
CN106068131A (en) 2016-11-02
NZ721597A (en) 2022-07-01
IL246407A0 (en) 2016-08-31
WO2015097236A2 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
HK1225657A1 (en) Fgf-18 formulation in alginate/collagen hydrogels
EP2804577A4 (en) Colour changing composition in gel form
HK1203317A1 (en) Edible composition, preparation method and use thereof
EP3044695A4 (en) Sharing artifacts in permission-protected archives
EP3070128A4 (en) Hydrogel-forming composition and hydrogel made therefrom
HUE048583T2 (en) Polymer based hydrogel
EP2972349A4 (en) Polymer dot compositions and related methods
PL2916855T3 (en) Collagen hydrolyzate and use thereof
EP2997270A4 (en) Improvements in karabiners
HK1203398A1 (en) Edible composition, preparation method and use thereof
EP3017642A4 (en) Performing measurements in wireless network
EP3054919A4 (en) Redox signaling gel formulation
IL245140A0 (en) Compositions and methods relating to an occlusive polymer hydrogel
HK1203397A1 (en) Edible composition, preparation method and use thereof
HK1221639A1 (en) Crosslinked chitosan lactide hydrogels
EP3060061A4 (en) Use of probiotics in meat
EP2938348A4 (en) Alginate compositions and uses thereof
EP3057439A4 (en) Protein-containing dietary compositions and methods for their preparation and use
IL234240B (en) Gelling formulation based on calcium gluconate
HK1221417A1 (en) Modified hydrogels
EP2967087A4 (en) Reducing mold in baked foods
IL246435A0 (en) Gel comprising fgf-18
EP3000867A4 (en) Fat composition
ZA201600037B (en) Organometallic 2-cyano-2-aminobenzoate-propyl derivates and their use as anthelmintics
GB2519072B (en) Composition comprising collagen and honey